Provide feedback
Search
Subscribe
Login
I need to set up an account
Hematology/Oncology
Hematology/Oncology
Conferences
Breast Cancer
Prostate Cancer
More Specialties
Cardiology
Dermatology
Endocrinology
Gastroenterology
Infectious Disease
Internal Medicine
Nephrology
Neurology
Hematology/Oncology
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonary/Respiratory
Rheumatology
Urology
Women's Health
FDA News
Managed Care
FDA lifts hold on Adolor's Entereg in chronic opioid bowel dysfunction; GSK may opt out of agreement for drug in this indication
FDA approves Abbott's Xience V everolimus-eluting stent system for coronary artery disease
In Brief: VioQuest Pharmaceuticals Inc.
FDA advisory committee recommends developers of diabetes drugs include cardiovascular safety, efficacy data
FDA cautions against using protein in cervical spine
Medicare Advantage plans underestimated spending projections in 2005, researchers find
New survey reveals consumer preferences in health care
In Brief: RxHub LLC
In Brief: President Bush
In Brief: Department of Health and Human Services
Home
::
Hematology/Oncology
:: Hematology/Oncology Conferences
30th Annual SABCS
December 12-16, 2007 San Antonio, Texas
Docetaxel plus cyclophosphamide improves overall survival better than standard chemotherapy in women with breast cancer, data show
Completion axillary dissection may not be required after positive sentinel node biopsy
Denosumab increases BMD in women with breast cancer receiving AI therapy, findings indicate
Continuation of tamoxifen beyond standard 5 years reduces breast cancer recurrence, preliminary data show
Micrometastatic deposits in sentinel nodes may play role in treatment decisions, data show
More
Most Read
Most Emailed
Radiotherapy, chemotherapy increase risks of second malignancy, cardiovascular disease similar to smoking in patients with testicular cancer, researchers report
Inappropriate treatment utilization common among patients with prostate cancer, study shows
Prostate cancer screening may provide mortality benefit, study data indicate
High pretreatment prostate-specific antigen velocity associated with development of distant metastasis, disease-specific mortality in patients with prostate cancer, data show
Subset of patients with castrate-refractory prostate cancer experience PSA response, increased survival following antiandrogen withdrawal, study data show
Radiotherapy, chemotherapy increase risks of second malignancy, cardiovascular disease similar to smoking in patients with testicular cancer, researchers report
ASCO publishes new guidelines for use of tumor marker tests to diagnose, manage breast cancer
Prostatectomy provides greatest long-term survival in patients with localized prostate cancer, study data suggest
Men with biopsy Gleason score 7, tertiary grade 5 disease face similar risk of PSA recurrence as men with higher Gleason score disease, study data suggest
Overweight men with advanced, androgen-dependent prostate cancer have better overall, progression-free survival than do men of normal weight, study results indicate